Several extremely interesting new developments have taken place in clinical cancer research in the past year. Cellular pharmacology of anti-neoplastic agents has continued gathering momentum. More insight has been acquired into the mechanisms of drug resistance where multi-drug resistance (MDR) is the center of interest. It is important in this research to define clinical resistance at the cellular level by using tumor biopsies from patients sensitive...